One of the biggest factors affecting rates of patient recruitment for clinical trials is the number of people who initially apply that can’t then be contacted in order to get them to go through an initial screening process.

In order to mitigate against this issue, we can implement different strategies to ensure as many of the initial applicants are contacted as possible.

For example, sending an immediate response via the patient’s chosen method, such as text or email. Or having them download an app, or communicate with a chatbot if they’ve applied online. Or have someone follow up with a swift phone call – the nearer to the time of the application being submitted the better.

The key factor is to be able to provide a range of options that suit their circumstances – enabling us to contact them in a timely manner and not have them simply become another person who is ‘uncontactable’.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...